The field of gene therapy has moved from promising scientific research to medical reality. With the potential to permanently correct genetic disorders with a one-time treatment, many gene therapies ...
Vaccines based on replication-defective adenoviral vectors are being developed for infectious agents and tumor-associated antigens. Early work focused on vaccines derived from a common human serotype ...
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the VanEck Vectors Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched ...
Hosted on MSN
VanEck Vectors Emerging Markets High Yield Bond ETF declares monthly distribution of $0.1124
VanEck Vectors Emerging Markets High Yield Bond ETF (NYSEARCA:HYEM) - $0.1124. 30-Day SEC Yield of 6.83% as of Aug. 29. Payable Sep 05; for shareholders of record Sep 02; ex-div Sep 02. HYEM: ...
Brazil bonds make it to the top of the list for a new exchange traded fund investing in Latin America debt. Van Eck Global's ETF brand, Market Vectors, launched its LatAm Aggregate Bond Fund (BONO) on ...
Launched on 12/20/2011, the VanEck Vectors Pharmaceutical ETF (PPH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback